Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Feb. 11, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
Formulations, Dosing, Devices, Markets and Forecasts
The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent dosing is believed to improve patient safety, reduce the incidence of injection site complications and improve compliance with drug protocols. Sustained release formulations mitigate the bolus effect at the time of injection, and thus have a salutary influence on drug side effects. All of these advantages, along with the need for fewer patient caregiver visits (for practitioner-administered drugs) have a positive, downward impact on overall healthcare costs. Currently approved sustained release injectables rely on a spectrum of branded formulation technologies to modulate the drug's release profile post-injection. Typically off-patent or generic drugs, they include drug therapies for almost a dozen major therapeutic segments, including neurological conditions, metabolic diseases, oncology, pain management and reproductive health. As the incidence and prevalence of chronic illnesses increases with the aging population, the attraction and interest in sustained release injectables will increase.
Key Topics Covered:
Injectable Drug Market Dynamics
The Trend toward Self-Administration
Injectable Drug Formulation Technology
Innovation in Injectable Device Designs
Therapeutic Demand Drivers
Sustained Release Injectables - Branded Formulation Technologies
Branded SR Formulation Technologies
Approved Sustained Release Injectables by Therapeutic Indication
Development-Stage SR Injectable Drug Candidate Assessment
SR Injectables - Therapeutic Sector Impact Analysis & Forecasts
Sustained Release Injectables - Company Profiles
For more information visit http://www.researchandmarkets.com/research/5nldqw/sustained_release
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.